Qin, Chenyuan Hu, Jiawei Wan, Yiming Cai, Mengyao Wang, Zhenting Peng, Zhao Liao, Yuxiao Li, Dan Yao, Ping Liu, Liegang
...
Published in
Progress in neuro-psychopharmacology & biological psychiatry
As a neuropsychiatric disorder, substance addiction represents a major public health issue with high prevalence and mortality in many countries. Recently, gut microbiota has been certified to play a part in substance addiction through various mechanisms. Hence, we mainly focused on three substance including alcohol, cocaine and methamphetamine in t...
Garani, Ranjini Watts, Jeremy J Mizrahi, Romina
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Despite widespread evidence of endocannabinoid system involvement in the pathophysiology of psychiatric disorders, our understanding remains rudimentary. Here we review studies of the endocannabinoid system in humans with psychotic and mood disorders. Postmortem, peripheral, cerebrospinal fluid and in vivo imaging studies provide evidence for the r...
Cupaioli, Francesca A Zucca, Fabio A Caporale, Cinzia Lesch, Klaus-Peter Passamonti, Luca Zecca, Luigi
Published in
Progress in neuro-psychopharmacology & biological psychiatry
In modern societies, there is a strive to improve the quality of life related to risk of crimes which inevitably requires a better understanding of brain determinants and mediators of aggression. Neurobiology provides powerful tools to achieve this end. Pre-clinical and clinical studies show that changes in regional volumes, metabolism-function and...
Stringfield, Sierra J Torregrossa, Mary M
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Cannabis is the most widely used illicit substance among adolescents, and adolescent cannabis use is associated with various neurocognitive deficits that can extend into adulthood. A growing body of evidence supports the hypothesis that adolescence encompasses a vulnerable period of development where exposure to exogenous cannabinoids can alter the...
Zhornitsky, Simon Pelletier, Julie Assaf, Roxane Giroux, Sarah Li, Chiang-Shan R Potvin, Stephane
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Impairment in cognition is frequently associated with acute cannabis consumption. However, some questions remain unanswered as to which deficits are most prominent and which demographic groups are most vulnerable. A literature search yielded 52 experimental studies of acute administration of partial CB1 receptor agonists (i.e. cannabis, THC, and na...
Zhang, Jianbo Deji, Cuola Fan, Jingna Chang, Liao Miao, Xinyao Xiao, Yifan Zhu, Yongsheng Li, Shengbin
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Substance addiction is a chronic and complicated disease involving genetic and environmental factors. Coregulated by the above factors, perturbations of the gut microbiome have been shown to have an essential role in the development of many neuropsychiatric disorders, including addiction. However, shifts in the gut microbiome during different stage...
Morand-Beaulieu, Simon Aardema, Frederick O'Connor, Kieron P Lavoie, Marc E
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Obsessive-compulsive disorder (OCD) patients are known to have various functional abnormalities in prefrontal and motor areas. Given the presence of compulsions in many OCD patients, impaired response preparation processes could be a core feature of OCD. Yet, these processes remain understudied from a neurophysiological standpoint. Nineteen OCD pat...
da Silva, Flaviane Cristine Troglio Neto, Modesto Leite Rolim
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Health professionals are key personnel to containing infectious diseases like COVID-19. In the face of long work shifts (that reach 16 h per day on average), the risk of getting infected by a high-infectious disease and the lack of enough biological protection measures, mental suffering among health professionals suddenly became evident. We carried...
Na, Kyoung-Sae Kim, Yong-Ku
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Ketamine was initially used as an anesthetic which could induce cognitive impairment and psychomimetic effects. In initial randomized controlled trials (RCTs) that mostly included a small sample size and were investigator-initiated, ketamine reportedly exerted antidepressant effects 1 to 2 h after a single intravenous infusion in patients with majo...
da Silva, Flaviane Cristine Troglio Neto, Modesto Leite Rolim
Published in
Progress in neuro-psychopharmacology & biological psychiatry
Psychological suffering by health professionals may be associated with the uncertainty of a safe workplace. Front-line professionals exposed and involved in the diagnosis and treatment of COVID-19 patients are more susceptible. This review was conducted based on papers that were published at MEDLINE, BMJ, PsycINFO, and LILACS, the according to the ...
